يعرض 301 - 320 نتائج من 21,342 نتيجة بحث عن '(( ((significant event) OR (significant adverse)) decrease ) OR ( significant decrease decrease ))', وقت الاستعلام: 0.57s تنقيح النتائج
  1. 301

    Medicare clozapine data analysis. حسب Luke R. Cavanah (19022435)

    منشور في 2025
    الموضوعات:
  2. 302
  3. 303
  4. 304
  5. 305
  6. 306
  7. 307
  8. 308
  9. 309
  10. 310

    Cohort characteristics. حسب Fernanda Talarico (807333)

    منشور في 2024
    الموضوعات:
  11. 311

    Table1_Adverse event profile differences between pralsetinib and selpercatinib: a real-world study based on the FDA adverse events reporting system.docx حسب Qiong Jie (13270095)

    منشور في 2024
    "…Aims<p>The objective of this study is to compare the adverse events (AEs) associated with pralsetinib and selpercatinib.…"
  12. 312

    Image2_Adverse event profile differences between pralsetinib and selpercatinib: a real-world study based on the FDA adverse events reporting system.TIF حسب Qiong Jie (13270095)

    منشور في 2024
    "…Aims<p>The objective of this study is to compare the adverse events (AEs) associated with pralsetinib and selpercatinib.…"
  13. 313

    Table2_Adverse event profile differences between pralsetinib and selpercatinib: a real-world study based on the FDA adverse events reporting system.docx حسب Qiong Jie (13270095)

    منشور في 2024
    "…Aims<p>The objective of this study is to compare the adverse events (AEs) associated with pralsetinib and selpercatinib.…"
  14. 314

    Image1_Adverse event profile differences between pralsetinib and selpercatinib: a real-world study based on the FDA adverse events reporting system.TIF حسب Qiong Jie (13270095)

    منشور في 2024
    "…Aims<p>The objective of this study is to compare the adverse events (AEs) associated with pralsetinib and selpercatinib.…"
  15. 315
  16. 316
  17. 317

    Study flow chart. حسب Benjamin R. Lewis (22279166)

    منشور في 2025
    الموضوعات:
  18. 318

    Study CONSORT diagram. حسب Benjamin R. Lewis (22279166)

    منشور في 2025
    الموضوعات:
  19. 319
  20. 320